Cargando…

Body mass index and leptin levels in serum and cerebrospinal fluid in relation to delayed cerebral ischemia and outcome after aneurysmal subarachnoid hemorrhage

Aneurysmal subarachnoid hemorrhage (SAH) is associated with a high mortality rate and may leave surviving patients severely disabled. After the initial hemorrhage, clinical outcome is further compromised by the occurrence of delayed cerebral ischemia (DCI). Overweight and obesity have previously bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Veldeman, Michael, Weiss, Miriam, Simon, Tim Philipp, Hoellig, Anke, Clusmann, Hans, Albanna, Walid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593057/
https://www.ncbi.nlm.nih.gov/pubmed/33866464
http://dx.doi.org/10.1007/s10143-021-01541-1
_version_ 1784599629361315840
author Veldeman, Michael
Weiss, Miriam
Simon, Tim Philipp
Hoellig, Anke
Clusmann, Hans
Albanna, Walid
author_facet Veldeman, Michael
Weiss, Miriam
Simon, Tim Philipp
Hoellig, Anke
Clusmann, Hans
Albanna, Walid
author_sort Veldeman, Michael
collection PubMed
description Aneurysmal subarachnoid hemorrhage (SAH) is associated with a high mortality rate and may leave surviving patients severely disabled. After the initial hemorrhage, clinical outcome is further compromised by the occurrence of delayed cerebral ischemia (DCI). Overweight and obesity have previously been associated with protective effects in the post-bleeding phase. The aim of this study was to assess the effects of a patient’s body mass index (BMI) and leptin levels on the occurrence of DCI, DCI-related cerebral infarction, and clinical outcome. In total, 263 SAH patients were included of which leptin levels were assessed in 24 cases. BMI was recorded along disease severity documented by the Hunt and Hess and modified Fisher scales. The occurrence of clinical or functional DCI (neuromonitoring, CT Perfusion) was assessed. Long-term clinical outcome was documented after 12 months (extended Glasgow outcome scale). A total of 136 (51.7%) patients developed DCI of which 72 (27.4%) developed DCI-related cerebral infarctions. No association between BMI and DCI occurrence (P = .410) or better clinical outcome (P = .643) was identified. Early leptin concentration in serum (P = .258) and CSF (P = .159) showed no predictive value in identifying patients at risk of unfavorable outcomes. However, a significant increase of leptin levels in CSF occurred from 326.0 pg/ml IQR 171.9 prior to DCI development to 579.2 pg/ml IQR 211.9 during ongoing DCI (P = .049). In our data, no association between obesity and clinical outcome was detected. After DCI development, leptin levels in CSF increased either by an upsurge of active transport or disruption of the blood-CSF barrier. This trial has been registered at ClinicalTrials.gov (NCT02142166) as part of a larger-scale prospective data collection. BioSAB: https://clinicaltrials.gov/ct2/show/NCT02142166 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10143-021-01541-1.
format Online
Article
Text
id pubmed-8593057
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-85930572021-11-19 Body mass index and leptin levels in serum and cerebrospinal fluid in relation to delayed cerebral ischemia and outcome after aneurysmal subarachnoid hemorrhage Veldeman, Michael Weiss, Miriam Simon, Tim Philipp Hoellig, Anke Clusmann, Hans Albanna, Walid Neurosurg Rev Original Article Aneurysmal subarachnoid hemorrhage (SAH) is associated with a high mortality rate and may leave surviving patients severely disabled. After the initial hemorrhage, clinical outcome is further compromised by the occurrence of delayed cerebral ischemia (DCI). Overweight and obesity have previously been associated with protective effects in the post-bleeding phase. The aim of this study was to assess the effects of a patient’s body mass index (BMI) and leptin levels on the occurrence of DCI, DCI-related cerebral infarction, and clinical outcome. In total, 263 SAH patients were included of which leptin levels were assessed in 24 cases. BMI was recorded along disease severity documented by the Hunt and Hess and modified Fisher scales. The occurrence of clinical or functional DCI (neuromonitoring, CT Perfusion) was assessed. Long-term clinical outcome was documented after 12 months (extended Glasgow outcome scale). A total of 136 (51.7%) patients developed DCI of which 72 (27.4%) developed DCI-related cerebral infarctions. No association between BMI and DCI occurrence (P = .410) or better clinical outcome (P = .643) was identified. Early leptin concentration in serum (P = .258) and CSF (P = .159) showed no predictive value in identifying patients at risk of unfavorable outcomes. However, a significant increase of leptin levels in CSF occurred from 326.0 pg/ml IQR 171.9 prior to DCI development to 579.2 pg/ml IQR 211.9 during ongoing DCI (P = .049). In our data, no association between obesity and clinical outcome was detected. After DCI development, leptin levels in CSF increased either by an upsurge of active transport or disruption of the blood-CSF barrier. This trial has been registered at ClinicalTrials.gov (NCT02142166) as part of a larger-scale prospective data collection. BioSAB: https://clinicaltrials.gov/ct2/show/NCT02142166 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10143-021-01541-1. Springer Berlin Heidelberg 2021-04-17 2021 /pmc/articles/PMC8593057/ /pubmed/33866464 http://dx.doi.org/10.1007/s10143-021-01541-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Veldeman, Michael
Weiss, Miriam
Simon, Tim Philipp
Hoellig, Anke
Clusmann, Hans
Albanna, Walid
Body mass index and leptin levels in serum and cerebrospinal fluid in relation to delayed cerebral ischemia and outcome after aneurysmal subarachnoid hemorrhage
title Body mass index and leptin levels in serum and cerebrospinal fluid in relation to delayed cerebral ischemia and outcome after aneurysmal subarachnoid hemorrhage
title_full Body mass index and leptin levels in serum and cerebrospinal fluid in relation to delayed cerebral ischemia and outcome after aneurysmal subarachnoid hemorrhage
title_fullStr Body mass index and leptin levels in serum and cerebrospinal fluid in relation to delayed cerebral ischemia and outcome after aneurysmal subarachnoid hemorrhage
title_full_unstemmed Body mass index and leptin levels in serum and cerebrospinal fluid in relation to delayed cerebral ischemia and outcome after aneurysmal subarachnoid hemorrhage
title_short Body mass index and leptin levels in serum and cerebrospinal fluid in relation to delayed cerebral ischemia and outcome after aneurysmal subarachnoid hemorrhage
title_sort body mass index and leptin levels in serum and cerebrospinal fluid in relation to delayed cerebral ischemia and outcome after aneurysmal subarachnoid hemorrhage
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593057/
https://www.ncbi.nlm.nih.gov/pubmed/33866464
http://dx.doi.org/10.1007/s10143-021-01541-1
work_keys_str_mv AT veldemanmichael bodymassindexandleptinlevelsinserumandcerebrospinalfluidinrelationtodelayedcerebralischemiaandoutcomeafteraneurysmalsubarachnoidhemorrhage
AT weissmiriam bodymassindexandleptinlevelsinserumandcerebrospinalfluidinrelationtodelayedcerebralischemiaandoutcomeafteraneurysmalsubarachnoidhemorrhage
AT simontimphilipp bodymassindexandleptinlevelsinserumandcerebrospinalfluidinrelationtodelayedcerebralischemiaandoutcomeafteraneurysmalsubarachnoidhemorrhage
AT hoelliganke bodymassindexandleptinlevelsinserumandcerebrospinalfluidinrelationtodelayedcerebralischemiaandoutcomeafteraneurysmalsubarachnoidhemorrhage
AT clusmannhans bodymassindexandleptinlevelsinserumandcerebrospinalfluidinrelationtodelayedcerebralischemiaandoutcomeafteraneurysmalsubarachnoidhemorrhage
AT albannawalid bodymassindexandleptinlevelsinserumandcerebrospinalfluidinrelationtodelayedcerebralischemiaandoutcomeafteraneurysmalsubarachnoidhemorrhage